Navigation Links
Hospira Announces Plans to Integrate Symbiq(R) and EndoTool(R) Technologies
Date:5/19/2009

-- Prototype of the Innovative Combined Technology on Demonstration at AACN Expo --

LAKE FOREST, Ill., May 19 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced the coming integration of its clinician-friendly Symbiq(R) smart infusion pump and industry-leading EndoTool(R) glucose management software. A prototype of this technologically advanced combination system is being demonstrated at the American Association of Critical Care Nurses (AACN) National Teaching Institute & Critical Care Exposition in New Orleans through May 21.

"Unveiling the integrated Symbiq and EndoTool development effort illustrates Hospira's commitment to providing cutting-edge medication delivery technology, and ensuring compatibility between and integration of important hospital technologies," said Philip Settimi, M.D., vice president, Global Marketing, Global Devices, Hospira.

As a leading provider of advanced medication delivery systems, Hospira offers hospitals and health institutions innovative solutions to improve clinician efficiency and patient safety. The Symbiq infusion system, which helps prevent medication errors, and the EndoTool glucose management system, a clinical-decision support tool designed to aid workflow, are novel technologies created with clinician input throughout the development process to ensure maximum usability. The AACN Expo attendees will be able to provide feedback regarding the integrated Symbiq/EndoTool system.

The Symbiq infusion system is a highly advanced, easy-to-use device with several clinician-friendly features to help improve workflow and decrease medication errors. An estimated 1.5 million medication errors occur annually, with 400,000 preventable drug-related injuries occurring in
'/>"/>

SOURCE Hospira, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Hospira Names Brian Meadows Supply Chain Chief
2. Hospira Supports Newly Introduced Biogenerics Legislation
3. Hospira Advances Patient Safety With New GemStar(R) SP Infusion System
4. StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists
5. Hospira Hosts Conference Call for Third-Quarter 2008 Earnings
6. Human Genome Sciences Announces Process Development and Manufacturing Alliance With Hospira
7. Hospira Expands Board of Directors
8. Hospiras Biosimilar Epoetin Retacrit(TM) Receives Positive Opinion Recommending EU Approval
9. Biogenerics Will Save Billions, Says Hospira CEO
10. Techne Corporation Announces the Retirement of G. Arthur Herbert, a Member of Its Board of Directors
11. Techne Corporation Announces That John L. Higgins has Accepted a Seat on Technes Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... April 16, 2015 Cambridge ... solutions driven by Semantic Web technology, and ... information and services for the academic and scientific, ... its joint solution ‘Smart Data Lake for Clinical ... for the 2015 Bio-IT ‘Best of Show’ Award. ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 Regis Technologies ... American Association for Cancer Research (AACR) annual meeting. Regis ... Convention Center, starting Saturday, April 18, in Philadelphia and ... claim to title of the oldest and largest organization ... fellowships and grants, and partners with survivors to promote ...
(Date:4/16/2015)... TORONTO , April 16, 2015 /PRNewswire/ - Portage ... PTGEF, Canadian Securities Exchange: PBT.U), is pleased to announce ... Investor Show on April 25, 2015 to be held ... Dr. Gregory Bailey and Mr. James ... overview and an update on the key programs at ...
(Date:4/16/2015)... , April 16, 2015  AnaptysBio, Inc., ... of therapeutic antibodies, today announced the advancement ... program into IND-enabling studies. The Company,s anti-IL-36R ... treatment for generalized pustular psoriasis (GPP), an ... medical need. ANB019 is wholly owned within AnaptysBio,s ...
Breaking Biology Technology:Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 3Regis Technologies Joins American Association for Cancer Research Annual Meeting 2Portage to Present at Master Investor 2015 in London, UK 2Portage to Present at Master Investor 2015 in London, UK 3Portage to Present at Master Investor 2015 in London, UK 4AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2
... a long-planned departure from its traditional focus, high-end computer ... U.S. Army for development of two different products. , ... it has secured $2.2 million in federal contracts for ... the Armys Research, Development and Engineering Command (CERDEC) to ...
... Inc. for the quarter ended March 31 rose to $142.5 ... company earned the same quarter of 2004. , ,Profit for ... even $150 million, compared to $78.3 million a year ago. ... more than $10 per share Tuesday and Wednesday from Monday's ...
... Milwaukee Merge eFilm , the Milwaukee-based ... Inc., continued to build momentum leading into its proposed ... net sales of just more than $10.5 million in ... first quarter 2004, after a 19 percent year-over-year jump ...
Cached Biology Technology:SLE of Eau Claire lands $2.2 million in federal contracts 2SLE of Eau Claire lands $2.2 million in federal contracts 3Merge eFilm earnings jump precedes planned merger 2Merge eFilm earnings jump precedes planned merger 3
(Date:4/14/2015)... YORK , April 14, 2015  HYPR ... IDentity Online (FIDO ® ) Alliance tm , ... specifications. FIDO members commit to share technology and ... methods that are interoperable, more secure and private, ... enable biometric identity verification that protects sensitive user ...
(Date:4/9/2015)... 9, 2015 Synaptics Inc. (NASDAQ: SYNA ), ... that it will report financial results for the third ... after the close of market. The company will host ... 2:00 p.m. PT (5:00 p.m. ET), during which management ... on the live call, analysts and investors should dial ...
(Date:4/2/2015)... GOTHENBURG, Sweden , April 2, 2015 ... revenues for Q1 2015 attributed to somewhat higher than ... company in the year-end report 2014 that revenues for ... MSEK that the company reported for Q4 2014. The ... continue to be negative. The complete interim report will ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Synaptics to Report Third Quarter Results on April 23 2Fingerprint Cards Revises Revenues for Q1 2015 2
... controlled trial of fish oil given intravenously to patients ... exchange, reduces inflammatory chemicals and results in a shorter ... open access journal Critical Care investigated the ... solution for patients with sepsis, finding a significant series ...
... 1. Prescribed Opioids Associated with Significant Risk for ... oxycodone, have increased significantly over the past decade. As ... common, the deaths associated with opioids increase. Opioid overdose ... Researchers sought to determine the rate of opioid overdose ...
... MIT and Harvard Medical School have built targeted nanoparticles ... medicine, an advance that potentially provides an alternative to ... The particles, dubbed "nanoburrs" because they are coated with ... target proteins, can be designed to release their drug ...
Cached Biology News:Annals of Internal Medicine tip sheet for Jan. 19, 2010, issue 2Annals of Internal Medicine tip sheet for Jan. 19, 2010, issue 3New nanoparticles target cardiovascular disease 2
This spacer is required to use the Miniature FRENCH Pressure Cell (FA-003) with the Laboratory Press....
... (M-MLV RT) is an RNA-dependent DNA polymerase that ... messenger RNA templates (>5kb). The enzyme is a ... consists of a single subunit with a molecular ... M-MLV RT is weaker than the commonly used ...
... of Cell Cultures (ECACC) in conjunction with ... West of England, Bristol, UK, have produced ... of HER2, oestrogen and progresterone receptor assays. ... of formalin fixed, breast cancer cell lines; ...
... highly potent TURBO DNase (patent pending) in the ... in DNA removal capabilities. TURBO DNase is a ... much more efficient than wild type DNase I ... TURBO DNase binds DNA substrates 6-fold more tightly ...
Biology Products: